LOS ANGELES, August 20, 2008-- Herbalife Ltd. (NYSE:HLF), a global nutrition and direct selling company, announced that Dr. Linong Ji has joined the company's Nutrition Advisory Board.
The nutrition advisory board is comprised of leading experts around the world in the fields of nutrition and health who educate and train Herbalife independent distributors and, in China, sales employees on the principles of nutrition, physical activity and healthy lifestyle. The board is chaired by David Heber, M.D., Ph.D., director of the Center for Human Nutrition at the University of California, Los Angeles (UCLA).
Ji is the director of endocrinology department at the People's Hospital of Peking University in China and a co-director of the Peking University Diabetes Center. He is also the president of the Endocrine and Metabolic Physician Society under the Chinese Physician Association, chief editor of Chinese Journal of Diabetes, vice-president of the Chinese Diabetes Society and a member of the International Diabetes Federation Western Pacific Region (IDF-WPR).
Ji's studies are focused on clinical work in endocrine and research in molecular genetics of diabetes mellitus and its treatment.
Ji received his medical degree from Beijing Medical University. Between 1993 and 1996, he studied at the JOSLIN Diabetes Center of Harvard Medical School. From 1997 to 1999, he was a visiting associate professor of medicine at Harvard University.
There are currently 20 members to the board, representing 17 countries.
About Herbalife Ltd.
Herbalife is a global network marketing company that sells weight-management, nutritional supplements and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 66 countries through a network of more than 1.8 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to bring good nutrition to children. Please visit Herbalife Investor Relations for additional information.